Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165 - Test2 - elhamkhani - TriplyDB

Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165

Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165

http://www.wikidata.org/entity/Q28214421

about

sameAs

CCN2/connective tissue growth factor is essential for pericyte adhesion and endothelial basement membrane formation during angiogenesis Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis The transcription factor SOX18 regulates the expression of matrix metalloproteinase 7 and guidance molecules in human endothelial cells Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors SP100 inhibits ETS1 activity in primary endothelial cells Early VEGFR2 activation in response to flow is VEGF-dependent and mediated by MMP activity CCN5: biology and pathophysiology Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development Functions and mechanisms of action of CCN matricellular proteins Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers Unraveling insulin-like growth factor binding protein-3 actions in human disease Neutrophil-Derived Proteases in the Microenvironment of Pancreatic Cancer -Active Players in Tumor Progression Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.Matrix metalloproteinase 1: role in sarcoma biology Neutrophils and Granulocytic MDSC: The Janus God of Cancer Immunotherapy Roles for CCN2 in normal physiological processes Effect of connective tissue growth factor on hypoxia-inducible factor 1alpha degradation and tumor angiogenesis Novel transcription-factor-like function of human matrix metalloproteinase 3 regulating the CTGF/CCN2 gene Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling Phase 1 study of anti-CTGF monoclonal antibody in patients with diabetes and microalbuminuria Systemic expression of matrix metalloproteinase-9 in patients with cerebral arteriovenous malformations.MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation.The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy ADAMTS4 (aggrecanase-1) interaction with the C-terminal domain of fibronectin inhibits proteolysis of aggrecan.Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Conne Quantifying the proteolytic release of extracellular matrix-sequestered VEGF with a computational model.Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.Long term effect of curcumin in regulation of glycolytic pathway and angiogenesis via modulation of stress activated genes in prevention of cancer Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion.Creation, validation, and quantitative analysis of protein expression in vascular tissue microarrays.Cellular mechanisms of tissue fibrosis. 8. Current and future drug targets in fibrosis: focus on Rho GTPase-regulated gene transcription.Stage-specific control of connective tissue growth factor (CTGF/CCN2) expression in chondrocytes by Sox9 and beta-catenin.Inhibition of corneal neovascularization by topical and subconjunctival tigecycline.CCN1 and CCN2: blood brothers in angiogenic action.Proteolytic processing of connective tissue growth factor in normal ocular tissues and during corneal wound healing Cartilage-specific over-expression of CCN family member 2/connective tissue growth factor (CCN2/CTGF) stimulates insulin-like growth factor expression and bone growth.

P2860

Q21134800-227E7E3A-EB95-42D7-BB04-4059F49A8B6F Q21202775-C8C4944E-4E48-4645-876E-3033D61867B0 Q24304117-A90AEE58-B3CF-4FEE-8C97-F41845109CA5 Q24305041-012BE617-1712-4CEC-A666-7B4697325EF1 Q24321596-B53E99F1-E1C4-4DF2-A159-D4E80B5F8F07 Q24338434-110D4F31-671D-4AB7-998E-406353BD77BD Q24597040-985712BD-C669-47A2-8F21-0FAAE4E25057 Q24616861-926E90D6-F7A1-4956-A639-AF18646913D4 Q24642303-354FC920-6FD1-4E6D-B62D-5B9B6F715FBE Q24644869-7A9D8487-816F-4234-AB37-9E90A7269A13 Q24650060-763433E8-7DDE-4B96-947A-57FCCBCB3473 Q26765238-22521A31-B2A2-4ABA-ACE0-71D1431D1E18 Q26782080-B0849513-C651-4F40-8A3B-8EE778277D3E Q27000351-733CF441-1F5D-43E6-8275-DB7041CE14DE Q27315973-ABE75531-81E8-4BD7-92F7-E8479B134750 Q28069360-4C027E0B-1022-4BA7-8657-90A0B9A7C6A3 Q28246114-FC4D788B-89A0-4AB4-8E6B-428B8F09E5C0 Q28252815-48452EF6-1F25-4E80-AE29-6AB87D4D4F5E Q28263327-FB8B36E2-8639-4C0C-B2C3-2E88711361F2 Q28275409-4B7BD472-3841-444B-B222-3A3EFE3993F5 Q28471583-8EEE3D5E-B29B-4689-AE48-2AEA5D3E24D7 Q30431214-5A7D32F6-0141-4AA7-9890-4683533EEA55 Q30449965-1A77C908-F00B-4510-A677-C47E78940A54 Q30495880-9D71D0CE-E999-4A4D-93B1-BDC1B6EE4F99 Q30845192-68B7E11F-FB77-451D-A5E8-A0FC8771D645 Q31065939-EC1A0F22-FA4D-4A35-A251-9579A7BCAA50 Q31094862-312DAA17-D8E2-4E09-A8F5-C789EC171448 Q33202468-89BED5CB-5545-4394-8DF8-F5258602797D Q33301092-4F1EDCF3-2839-418E-AD56-B5D097704E38 Q33649673-03E6EAB3-F959-4312-8A2D-C2DE7AF88CB7 Q33665623-F4C0BD72-6403-4A77-9BDB-C9C5888BC9E4 Q33763348-22978F1E-5144-4239-B538-DADCAEE8F035 Q33768443-329B3657-D41B-472B-83F1-B0A7A22C459F Q33838256-59DCAC91-5ABA-4FD1-BB74-681AE0AFFB38 Q33840143-F3F4F201-32EA-4553-BF24-F81EB416126B Q34107237-CC759E8F-BF5C-43DD-8865-E1D9FFE0DFF4 Q34114441-5001194D-4534-481A-ADDC-2CED38709106 Q34352095-9404F5D4-FE3B-444E-A6A3-F6F3D829BA78 Q34471600-09ACD110-5C6C-4F67-BACA-9D96BFF64709 Q34650896-8EDB5CE7-C95D-417F-A745-7267EAF521EC

P2860

Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165

http://www.wikidata.org/entity/Q28214421

description

2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique Journal of Biological Chemistry

@fr

artículu científicu espublizáu en 2002

@ast

im September 2002 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 27 September 2002)

@en

vedecký článok (publikovaný 2002/09/27)

@sk

vědecký článek publikovaný v roce 2002

@cs

wetenschappelijk artikel (gepubliceerd op 2002/09/27)

@nl

наукова стаття, опублікована у вересні 2002

@uk

name

Matrix metalloproteinases clea ...... endothelial growth factor 165

@ast

Matrix metalloproteinases clea ...... endothelial growth factor 165

@en

Matrix metalloproteinases clea ...... endothelial growth factor 165

@nl

type

label

Matrix metalloproteinases clea ...... endothelial growth factor 165

@ast

Matrix metalloproteinases clea ...... endothelial growth factor 165

@en

Matrix metalloproteinases clea ...... endothelial growth factor 165

@nl

prefLabel

Matrix metalloproteinases clea ...... endothelial growth factor 165

@ast

Matrix metalloproteinases clea ...... endothelial growth factor 165

@en

Matrix metalloproteinases clea ...... endothelial growth factor 165

@nl

P1433

Q28214421-75420BF9-4582-4548-A83D-37EA654F79B1

P1476

Q28214421-ADFB4470-16A9-4940-A4D7-89F6642487B4

P2093

Q28214421-0B6C96C4-13C9-4BCC-8281-EC4C67D6B01C

Q28214421-4DDD0286-05FF-4349-9B96-5CFEB4D8541F

Q28214421-73EE0A4A-544F-4DFA-9A96-3E827D7B18D0

Q28214421-7C1730A4-714D-4568-9BB4-E3D9D6DC1CB3

Q28214421-8EAB695F-55C4-4391-9E7E-A35F7923C557

Q28214421-E939344A-C508-4773-B676-A2FB7ABDDE21

P2860

Q28214421-17233C11-8D12-46B9-A147-58D731FFA41B

Q28214421-173A0255-5660-4BC9-A0E7-DE172CF84B41

Q28214421-1B1886D2-8131-46AC-B9BE-365041AF0558

Q28214421-3BD224F1-F2DB-4986-A6C3-9E8C19BBE232

Q28214421-45F6B2F3-7E3A-492B-8009-929D044F9E95

Q28214421-46E5FCC4-7E30-494F-81C2-A8E1E83713BC

Q28214421-47344CA9-1529-4C5F-AFF6-280C64CA0392

Q28214421-4B063F9A-CD03-4EDA-AF88-6E4B4D02C788

Q28214421-4BA34F18-475E-40F8-8913-58D676F30544

Q28214421-4FF3C719-71B0-458F-8896-5E1B03A43BE2

P304

Q28214421-923DD736-CFE4-4C43-B98A-19C55257B136

P31

Q28214421-04D8BC24-88D9-463E-B7B9-CDDE4E5B4932

P3181

Q28214421-8BBA2544-DFEB-4DF3-B710-13B1A5F13132

P356

Q28214421-8460BECF-6429-4ACD-939F-6963AA934E66

P407

Q28214421-FD3FFD19-3F1E-4588-AF2E-AC0B4B6F335F

P433

Q28214421-9200E993-9118-49DD-BA83-5AE73113B8EA

P478

Q28214421-DEBF05B3-3436-452D-BB61-A18914707BCE

P577

Q28214421-FAA6EA17-4BCC-4839-9D46-4B2CF37253F4

P698

Q28214421-E3EFCE98-B1BF-4868-8091-94A613911243

P921

Q28214421-43B26B74-A750-4C3D-86DC-7234335C82AE

Q28214421-D1574386-DD90-43A2-8D62-8E0E84E4C71B

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Matrix metalloproteinases clea ...... endothelial growth factor 165

@en

P2093

Eiji Ikeda

http://www.w3.org/2001/XMLSchema#string

Gakuji Hashimoto

http://www.w3.org/2001/XMLSchema#string

Isao Inoki

http://www.w3.org/2001/XMLSchema#string

Takanori Aoki

http://www.w3.org/2001/XMLSchema#string

Yasunori Okada

http://www.w3.org/2001/XMLSchema#string

Yutaka Fujii

http://www.w3.org/2001/XMLSchema#string

P2860

Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4)

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides

Biochemical characterization of human collagenase-3

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain

Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites

Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3

Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties

P304

36288-95

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3589964

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M201674200

http://www.w3.org/2001/XMLSchema#string

P407

P433

39

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12114504

http://www.w3.org/2001/XMLSchema#string

P921

connective tissue